What is a stock summary page? Click here for an overview.
Business Description
Healius Ltd
ISIN : AU0000033359
Description
Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider, though the latter business is set to be sold in early 2025. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 1.36 | |||||
Debt-to-EBITDA | 6.6 | |||||
Interest Coverage | 1.51 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.65 | |||||
Beneish M-Score | -2.87 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.4 | |||||
3-Year FCF Growth Rate | -23.8 | |||||
3-Year Book Growth Rate | -19.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | -5.41 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -54.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.29 | |||||
Quick Ratio | 1.25 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 53.59 | |||||
Days Sales Outstanding | 38.45 | |||||
Days Payable | 310.59 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.6 | |||||
Shareholder Yield % | 19.13 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 85.72 | |||||
Operating Margin % | 2.8 | |||||
Net Margin % | -1.46 | |||||
FCF Margin % | 18.03 | |||||
ROE % | -2.19 | |||||
ROA % | -0.75 | |||||
ROIC % | 1.01 | |||||
3-Year ROIIC % | 3.71 | |||||
ROC (Joel Greenblatt) % | -3.03 | |||||
ROCE % | -1.6 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.97 | |||||
Forward PE Ratio | 60.63 | |||||
PE Ratio without NRI | 23.88 | |||||
PS Ratio | 0.64 | |||||
PB Ratio | 0.98 | |||||
Price-to-Tangible-Book | 21.64 | |||||
Price-to-Free-Cash-Flow | 3.51 | |||||
Price-to-Operating-Cash-Flow | 2.93 | |||||
EV-to-EBIT | -60.72 | |||||
EV-to-EBITDA | 10.81 | |||||
EV-to-Revenue | 1.47 | |||||
EV-to-Forward-Revenue | 1.45 | |||||
EV-to-FCF | 8.08 | |||||
Price-to-GF-Value | 0.81 | |||||
Price-to-Graham-Number | 4.77 | |||||
Earnings Yield (Greenblatt) % | -1.65 | |||||
FCF Yield % | 28.18 | |||||
Forward Rate of Return (Yacktman) % | 6.88 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PHCRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Healius Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,015.193 | ||
EPS (TTM) ($) | 0.049 | ||
Beta | -0.17 | ||
3-Year Sharpe Ratio | -0.7 | ||
3-Year Sortino Ratio | -0.7 | ||
Volatility % | 54.46 | ||
14-Day RSI | - | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 0.97 | ||
12-1 Month Momentum % | -54.46 | ||
52-Week Range ($) | 0.97 - 2.13 | ||
Shares Outstanding (Mil) | 726.13 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Healius Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Healius Ltd Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Healius Ltd Frequently Asked Questions
What is Healius Ltd(PHCRF)'s stock price today?
The current price of PHCRF is $0.97. The 52 week high of PHCRF is $2.13 and 52 week low is $0.97.
When is next earnings date of Healius Ltd(PHCRF)?
The next earnings date of Healius Ltd(PHCRF) is 2025-08-20 Est..
Does Healius Ltd(PHCRF) pay dividends? If so, how much?
Healius Ltd(PHCRF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |